Rankings
▼
Calendar
PTCT Q4 2021 Earnings — PTC Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
PTCT
PTC Therapeutics, Inc.
$6B
Q4 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$165M
+39.0% YoY
Gross Profit
$156M
94.4% margin
Operating Income
-$85M
-51.3% margin
Net Income
-$143M
-86.7% margin
EPS (Diluted)
$-2.03
QoQ Revenue Growth
+19.1%
Cash Flow
Operating Cash Flow
-$69M
Free Cash Flow
-$93M
Stock-Based Comp.
$26M
Balance Sheet
Total Assets
$1.9B
Total Liabilities
$1.9B
Stockholders' Equity
$1M
Cash & Equivalents
$190M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$165M
$119M
+39.0%
Gross Profit
$156M
$114M
+36.8%
Operating Income
-$85M
-$96M
+12.1%
Net Income
-$143M
-$74M
-92.7%
Geographic Segments
Non-US
$70M
59%
United States
$48M
41%
← FY 2021
All Quarters
Q1 2022 →